Results 191 to 200 of about 2,755,321 (217)

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy.

JAMA, 1986
Daily administration of isoniazid for one year to persons infected with Mycobacterium tuberculosis is effective in considerably reducing the risk of disease. From a practical viewpoint, this approach to prevention is less than ideal because it results in considerable costs as health care providers monitor for possible hepatotoxic effects and because it
D E, Snider, G J, Caras, J P, Koplan
openaire   +1 more source

Toxicity Associated With Isoniazid Preventive Therapy

JAMA, 1999
openaire   +2 more sources

Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, southwest Ethiopia: a retrospective study design

Journal of International Medical Research, 2021
Mecha Aboma, Nagasa Dida
exaly  

Preventive Therapy with Isoniazid for “Inactive” Tuberculosis

Chest, 1978
Dixie E. Snider, Laurence S. Farer
openaire   +1 more source

Decision Analysis for Isoniazid Preventive Therapy: Take It or Leave It

American Review of Respiratory Disease, 1988
J, Tsevat, W C, Taylor, J B, Wong, S G, Pauker   +3 more
openaire   +4 more sources

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts

International Journal of Environmental Research and Public Health, 2023
Amdehiwot Aynalem, Tsegahun Manyazewal, Mesfin Abebe   +2 more
exaly  

Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 2020
Edwin Charlebois, James Ayieko, Gabriel Chamie   +2 more
exaly  

Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data

Tropical Medicine and International Health, 2020
Carlos Seas, Larissa Otero
exaly  

Tests for latent tuberculosis infection and isoniazid preventive therapy

The Lancet Infectious Diseases, 2012
David W, Dowdy, Jonathan E, Golub
openaire   +2 more sources

Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study

Clinical Infectious Diseases, 2015
Lawrence Moulton, Valeria Saraceni, Solange Cavalcante   +2 more
exaly